Three-year disease-free remission in a xeroderma pigmentosum patient after adjuvant anti-PD-1 therapy

Eur J Cancer. 2022 Sep:173:207-209. doi: 10.1016/j.ejca.2022.06.050. Epub 2022 Aug 1.

Authors

Valerie Scheer¹, Oliver Schmalz², Percy Lehmann¹, Silke C Hofmann¹, Ulrich Wesselmann³

Affiliations

¹ Department of Dermatology, Allergology and Dermatosurgery, Helios University Hospital Wuppertal, University Witten/Herdecke, Germany.
² Department of Oncology, Helios University Hospital Wuppertal, University Witten/Herdecke, Germany.
³ Department of Dermatology, Allergology and Dermatosurgery, Helios University Hospital Wuppertal, University Witten/Herdecke, Germany. Electronic address: ulrich.wesselmann@helios-gesundheit.de.

PMID: 35926245
DOI: 10.1016/j.ejca.2022.06.050

No abstract available

Publication types

Letter

MeSH terms

Combined Modality Therapy
DNA Repair
Disease-Free Survival
Humans
Skin Neoplasms* / drug therapy
Xeroderma Pigmentosum* / drug therapy